PDZRN3 and neutropenia: An SNP of LNX3 in intron 3 associated with grade 4 neutropenia was identified through a GWAS of patients who suffered from severe neutropenia after treatment with irinotecan, a chemotherapeutic agent for the treatment of colorectal and lung cancers [139,140,141,142].